Synthesis, anti-cancer activity, Pim-3 inhibitory potency and zebrafish larvae toxicity evaluation of indolopyrazolocarbazole derivatives
Abstract
The pyrazole analogue of the staurosporine aglycone K252c (12,13-dihydro-5 H -indolo[2,3- a ]pyrazolo[3,4- c ]carbazole) was substituted on the indolocarbazole nitrogens by a functionalized three-carbon bridge leading to a series of hemiaminal, hemiaminal ether and aminal derivatives. Cytotoxicity of the new compounds was evaluated toward MOLM-13 acute myeloid leukemia (AML) cell line, identifying compounds 25 , 26 and 29 as highly potent with IC 50 values between 0.015 and 0.064 μM after 24 hours of incubation. These hits were further assessed for their activity against two neuroblastoma (NBL) cell lines (MHH-NB-11 and LAN-5), showing IC 50 values in the range of 0.51 μM to 1.3 μM. We also confirmed that Pim-3 kinase is one target for these pyrazole K252c analogues, even if there is no obvious correlation with the observed cytotoxities. Finally, toxicity toward zebrafish larvae was evaluated to assess the safety profile of compounds 25 , 26 and 29 . Our results demonstrated that the potency and therapeutic window of these hits are favorable for further in vivo study using AML or NBL models.
Related
- Chemical Synthesis and Immunological Evaluation of Archaeal Rare Sugar L-TalNAcA and Its Derivatives
- Design, Synthesis, and Evaluation of Novel Cephalotaxine-Cinnamic Acid Derivatives Against Hepatocellular Carcinoma
- Design, synthesis, and biological evaluation of novel 4,5-diaryl-1,2,3-thiadiazole derivatives: anticancer activity and molecular docking studies
- Design, Synthesis, In Vitro and In Silico Evaluation of Triazole–Benzimidazole Hybrid Derivatives as Potential Inhibitors of EGFR, EGFR-L858R, and EGFR-L858R/T790M
- Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors
BibTeX
@article{frazier2026synthesis,
title = {{Synthesis, anti-cancer activity, Pim-3 inhibitory potency and zebrafish larvae toxicity evaluation of indolopyrazolocarbazole derivatives}},
author = {Théo Frazier and Elisabeth Pereira and Reidun Aesoy and Andrea Trentani and Francis Giraud and Lars Herfindal and Fabrice Anizon and Pascale Moreau},
journal = {European Journal of Medicinal Chemistry Reports},
year = {2026},
month = oct,
doi = {10.1016/j.ejmcr.2026.100371},
url = {https://hal.science/hal-05784513v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Synthesis, anti-cancer activity, Pim-3 inhibitory potency and zebrafish larvae toxicity evaluation of indolopyrazolocarbazole derivatives
AU - Théo Frazier
AU - Elisabeth Pereira
AU - Reidun Aesoy
AU - Andrea Trentani
AU - Francis Giraud
AU - Lars Herfindal
AU - Fabrice Anizon
AU - Pascale Moreau
PY - 2026
DA - 2026/10/07
JO - European Journal of Medicinal Chemistry Reports
DO - 10.1016/j.ejmcr.2026.100371
UR - https://hal.science/hal-05784513v1
AB - The pyrazole analogue of the staurosporine aglycone K252c (12,13-dihydro-5 H -indolo[2,3- a ]pyrazolo[3,4- c ]carbazole) was substituted on the indolocarbazole nitrogens by a functionalized three-carbon bridge leading to a series of hemiaminal, hemiaminal ether and aminal derivatives. Cytotoxicity of the new compounds was evaluated toward MOLM-13 acute myeloid leukemia (AML) cell line, identifying compounds 25 , 26 and 29 as highly potent with IC 50 values between 0.015 and 0.064 μM after 24 hours of incubation. These hits were further assessed for their activity against two neuroblastoma (NBL) cell lines (MHH-NB-11 and LAN-5), showing IC 50 values in the range of 0.51 μM to 1.3 μM. We also confirmed that Pim-3 kinase is one target for these pyrazole K252c analogues, even if there is no obvious correlation with the observed cytotoxities. Finally, toxicity toward zebrafish larvae was evaluated to assess the safety profile of compounds 25 , 26 and 29 . Our results demonstrated that the potency and therapeutic window of these hits are favorable for further in vivo study using AML or NBL models.
SN - 2772-4174
ER -